CSPC Pharmaceutical Group (MEX:1093N) Cyclically Adjusted Revenue per Share: MXN4.24 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:1093N CSPC Pharmaceutical Group Ltd MEX:1093N
90 GF Score
Price MXN15.69
GF Value MXN12.81
! 4 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group Cyclically Adjusted Revenue per Share?

CSPC Pharmaceutical Group MEX:1093N 90 Cyclically Adjusted Revenue per Share is MXN4.24 as of Dec. 2025. GuruFocus rates MEX:1093N with a GF Score™ of 90/100 and a GF Value™ of MXN12.81. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

CSPC Pharmaceutical Group's adjusted revenue per share for the three months ended in Dec. 2025 was MXN1.368. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN4.24 for the trailing ten years ended in Dec. 2025.

During the past 12 months, CSPC Pharmaceutical Group's average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of CSPC Pharmaceutical Group was 7.90% per year. The lowest was 7.40% per year. And the median was 7.65% per year.

As of today (2026-08-12), CSPC Pharmaceutical Group's current stock price is MXN15.69. CSPC Pharmaceutical Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 was MXN4.24. CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio of today is 3.70.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CSPC Pharmaceutical Group was 7.74. The lowest was 2.06. And the median was 4.46.


CSPC Pharmaceutical Group  (MEX:1093N) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=15.69/4.24
=3.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CSPC Pharmaceutical Group was 7.74. The lowest was 2.06. And the median was 4.46.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


CSPC Pharmaceutical Group Cyclically Adjusted Revenue per Share Related Terms


CSPC Pharmaceutical Group Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for CSPC Pharmaceutical Group's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group Cyclically Adjusted Revenue per Share Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.34 0.00 4.24 6.99 4.24

CSPC Pharmaceutical Group Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.86 4.46 3.75 4.24 0.00

MEX:1093N vs LLY, JNJ, ABBV: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Cyclically Adjusted PS Ratio falls into.


MEX:1093N
90GF Score
CSPC Pharmaceutical Group Ltd MEX:1093N
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSPC Pharmaceutical Group Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CSPC Pharmaceutical Group's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=1.368/115.8323*115.8323
=1.368

Current CPI (Dec. 2025) = 115.8323.

CSPC Pharmaceutical Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 0.596 100.600 0.686
201603 0.577 102.200 0.654
201606 0.676 101.400 0.772
201609 0.681 102.400 0.770
201612 0.807 102.600 0.911
201703 0.723 103.200 0.811
201706 0.728 103.100 0.818
201709 0.785 104.100 0.873
201712 0.855 104.500 0.948
201803 1.035 105.300 1.139
201806 1.127 104.900 1.244
201809 1.175 106.600 1.277
201812 0.903 106.500 0.982
201903 1.326 107.700 1.426
201906 1.323 107.700 1.423
201909 1.296 109.800 1.367
201912 1.202 111.200 1.252
202003 1.708 112.300 1.762
202006 1.762 110.400 1.849
202009 1.797 111.700 1.863
202012 1.457 111.500 1.514
202103 1.765 112.662 1.815
202106 1.837 111.769 1.904
202109 1.817 112.215 1.876
202112 1.947 113.108 1.994
202203 2.073 114.335 2.100
202206 1.950 114.558 1.972
202212 0.000 115.116 0.000
202303 1.768 115.116 1.779
202306 1.616 114.558 1.634
202309 1.564 115.339 1.571
202312 1.519 114.781 1.533
202403 1.747 115.227 1.756
202406 1.557 114.781 1.571
202409 1.510 115.785 1.511
202412 1.543 114.893 1.556
202503 1.729 115.116 1.740
202506 1.436 114.907 1.448
202509 1.491 115.471 1.496
202512 1.368 115.832 1.368

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN4.24 mean?
CSPC Pharmaceutical Group (MEX:1093N) has a Cyclically Adjusted Revenue per Share of MXN4.24 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CSPC Pharmaceutical Group and its competitors.
Is CSPC Pharmaceutical Group's Cyclically Adjusted Revenue per Share too high?
CSPC Pharmaceutical Group's current Cyclically Adjusted Revenue per Share is MXN4.24. Overall, CSPC Pharmaceutical Group has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Cyclically Adjusted Revenue per Share compare to LLY and JNJ?
CSPC Pharmaceutical Group's Cyclically Adjusted Revenue per Share of MXN4.24 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CSPC Pharmaceutical Group and its competitors. CSPC Pharmaceutical Group's current Cyclically Adjusted Revenue per Share is MXN4.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
CSPC Pharmaceutical Group (MEX:1093N) has a current Cyclically Adjusted Revenue per Share of MXN4.24. The stock's GF Value™ is MXN12.81, compared to a current price of MXN15.69 — trading 22.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN4.24. CSPC Pharmaceutical Group's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For CSPC Pharmaceutical Group (MEX:1093N), the current Cyclically Adjusted Revenue per Share is MXN4.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSPC Pharmaceutical Group (MEX:1093N) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued. The current stock price of MXN15.69 is trading 22.5% above its estimated GF Value™ of MXN12.81.

Key valuation signals for MEX:1093N:

  • Cyclically Adjusted Revenue per Share: MXN4.24
  • GF Value™: MXN12.81 vs. price of MXN15.69 (22.5% above fair value)
  • GF Score™: 90/100 with 4 warning signs

No single metric tells the full story. See the MEX:1093N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
90GF Score

Get the complete analysis for MEX:1093N

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN15.69
Price
MXN12.81
GF Value